Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607

Watchlist Manager
Shanghai Pharmaceuticals Holding Co Ltd Logo
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Watchlist
Price: 17.9 CNY 0.06% Market Closed
Market Cap: 66.4B CNY

Intrinsic Value

The intrinsic value of one Shanghai Pharmaceuticals Holding Co Ltd stock under the Base Case scenario is 38.71 CNY. Compared to the current market price of 17.9 CNY, Shanghai Pharmaceuticals Holding Co Ltd is Undervalued by 54%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
38.71 CNY
Undervaluation 54%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Shanghai Pharmaceuticals Holding Co Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about Shanghai Pharmaceuticals Holding Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Shanghai Pharmaceuticals Holding Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Shanghai Pharmaceuticals Holding Co Ltd.

Explain Valuation
Compare Shanghai Pharmaceuticals Holding Co Ltd to

Fundamental Analysis

Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
CN
Health Care
Market Cap
66.4B CNY
IPO
Mar 24, 1994
CN
Health Care
Market Cap
66.4B CNY
IPO
Mar 24, 1994
Price
Â¥
Â¥
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Shanghai Pharmaceuticals Holding Co Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Shanghai Pharmaceuticals Holding Co Ltd

Current Assets 183.9B
Receivables 94.4B
Other Current Assets 89.5B
Non-Current Assets 52.8B
Long-Term Investments 8.9B
PP&E 19B
Intangibles 21.9B
Other Non-Current Assets 3B
Current Liabilities 139B
Accounts Payable 64.5B
Accrued Liabilities 1.8B
Short-Term Debt 44.5B
Other Current Liabilities 28.1B
Non-Current Liabilities 22B
Long-Term Debt 5.3B
Other Non-Current Liabilities 16.7B
Efficiency

Free Cash Flow Analysis
Shanghai Pharmaceuticals Holding Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Shanghai Pharmaceuticals Holding Co Ltd

Revenue
280.7B CNY
Cost of Revenue
-251.6B CNY
Gross Profit
29.1B CNY
Operating Expenses
-21.6B CNY
Operating Income
7.5B CNY
Other Expenses
-1.8B CNY
Net Income
5.6B CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Shanghai Pharmaceuticals Holding Co Ltd's profitability score is 44/100. The higher the profitability score, the more profitable the company is.

Sustainable 3Y Average Gross Margin
Healthy Gross Margin
Declining Net Margin
Declining Operating Margin
44/100
Profitability
Score

Shanghai Pharmaceuticals Holding Co Ltd's profitability score is 44/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Shanghai Pharmaceuticals Holding Co Ltd's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Average Altman Z-Score
53/100
Solvency
Score

Shanghai Pharmaceuticals Holding Co Ltd's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Shanghai Pharmaceuticals Holding Co Ltd

Wall Street analysts forecast Shanghai Pharmaceuticals Holding Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Shanghai Pharmaceuticals Holding Co Ltd is 20.71 CNY with a low forecast of 12.32 CNY and a high forecast of 25.66 CNY.

Lowest
Price Target
12.32 CNY
31% Downside
Average
Price Target
20.71 CNY
16% Upside
Highest
Price Target
25.66 CNY
43% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Shanghai Pharmaceuticals Holding Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Shanghai Pharmaceuticals Holding Co Ltd stock?

The intrinsic value of one Shanghai Pharmaceuticals Holding Co Ltd stock under the Base Case scenario is 38.71 CNY.

Is Shanghai Pharmaceuticals Holding Co Ltd stock undervalued or overvalued?

Compared to the current market price of 17.9 CNY, Shanghai Pharmaceuticals Holding Co Ltd is Undervalued by 54%.

Back to Top